These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 3147199

  • 1. The antibacterial activity of a new 3-azinomethyl-rifamycin.
    Strippoli V, Bruzzese T, Galli R, Simonetti N, Tronci N.
    Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of novel rifamycins against gram-positive clinical isolates.
    Murphy CK, Karginova E, Sahm D, Rothstein DM.
    J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
    [Abstract] [Full Text] [Related]

  • 3. Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials.
    Lohray BB, Lohray VB, Srivastava BK, Gupta S, Solanki M, Pandya P, Kapadnis P.
    Bioorg Med Chem Lett; 2006 Mar 15; 16(6):1557-61. PubMed ID: 16386420
    [Abstract] [Full Text] [Related]

  • 4. Novel rifamycins. I-Synthesis and antibacterial activity of 3-hydrazinorifamycin derivatives.
    Marsili L, Franceschi G, Gioia B, Oronzo G, Schioppacassi G, Vigevani A.
    Farmaco Sci; 1982 Oct 15; 37(10):641-50. PubMed ID: 6814953
    [Abstract] [Full Text] [Related]

  • 5. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
    Shorin VA, Shapovalova SP, Malkova IV.
    Antibiotiki; 1974 Dec 15; 19(12):1084-8. PubMed ID: 4155605
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and antibacterial evaluation of a novel series of rifabutin-like spirorifamycins.
    Kim IH, Combrink KD, Ma Z, Chapo K, Yan D, Renick P, Morris TW, Pulse M, Simecka JW, Ding CZ.
    Bioorg Med Chem Lett; 2007 Mar 01; 17(5):1181-4. PubMed ID: 17189695
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.
    Rothstein DM, Farquhar RS, Sirokman K, Sondergaard KL, Hazlett C, Doye AA, Gwathmey JK, Mullin S, van Duzer J, Murphy CK.
    Antimicrob Agents Chemother; 2006 Nov 01; 50(11):3658-64. PubMed ID: 16940074
    [Abstract] [Full Text] [Related]

  • 8. Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins.
    Li J, Ma Z, Chapo K, Yan D, Lynch AS, Ding CZ.
    Bioorg Med Chem Lett; 2007 Oct 15; 17(20):5510-3. PubMed ID: 17826091
    [Abstract] [Full Text] [Related]

  • 9. Antibacterial activity of Thymus daenensis methanolic extract.
    Mojab F, Poursaeed M, Mehrgan H, Pakdaman S.
    Pak J Pharm Sci; 2008 Jul 15; 21(3):210-3. PubMed ID: 18614414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro antibacterial effects of topical local anesthetics.
    Sedef Gocmen J, Buyukkocak U, Caglayan O, Aksoy A.
    J Dermatolog Treat; 2008 Jul 15; 19(6):351-3. PubMed ID: 18608709
    [Abstract] [Full Text] [Related]

  • 12. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I.
    Surg Gynecol Obstet; 1987 Dec 15; 165(6):491-5. PubMed ID: 3317944
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice.
    Craven N, Anderson JC.
    Am J Vet Res; 1983 Apr 15; 44(4):709-12. PubMed ID: 6553464
    [Abstract] [Full Text] [Related]

  • 14. New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases.
    Combrink KD, Denton DA, Harran S, Ma Z, Chapo K, Yan D, Bonventre E, Roche ED, Doyle TB, Robertson GT, Lynch AS.
    Bioorg Med Chem Lett; 2007 Jan 15; 17(2):522-6. PubMed ID: 17070048
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.
    Trampuz A, Murphy CK, Rothstein DM, Widmer AF, Landmann R, Zimmerli W.
    Antimicrob Agents Chemother; 2007 Jul 15; 51(7):2540-5. PubMed ID: 17502404
    [Abstract] [Full Text] [Related]

  • 18. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT, Li Y, Wang J, China Bacterial Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):365-74. PubMed ID: 12820911
    [Abstract] [Full Text] [Related]

  • 19. [Sensitivity of bacteria isolated from non-parenteral drugs to antibiotics. II. Sensitivity of gram-positive strains].
    Zembrzuska E.
    Acta Pol Pharm; 1981 Mar 10; 38(1):123-8. PubMed ID: 6797259
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.